15:59 Dec 20
Lyka Labs Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Lyka Labs Ltd.
43/100 Medium Financial Strength
Quality19/100 Expensive Valuation
Valuation60/100 Technically Moderately Bullish
TechnicalSWOT
Strength
6
Weakness
6
Opportunity
0
Threat
0
534.42
Market Cap (Cr)
143.08
PE Ratio
5.40
Price to Book Ratio
RSI
-2.23 %
Net Profit Margin
SWOT
Download Our App On:
